Interactive Multi-Omics Data Exploration, Cohort Discovery, and Biological Insight Platform
Enterprise bioinformatics software platform empowering translational scientists and clinicians to ingest, integrate, query, and visualize petabyte-scale multi-omics datasets (genomics, bulk and single-cell transcriptomics, proteomics, metabolomics, and spatial biology) alongside clinical trial metadata through intuitive, code-free visual analytics dashboards.
1 · What it gives
Interactive Multi-Omics Data Exploration, Cohort Discovery, and Biological Insight Platform defines an essential paradigm in digital life sciences, computational biology, and artificial intelligence-driven healthcare infrastructure. By integrating cloud-native microservices, deep learning neural networks (transformers, diffusion models, graph neural networks), physics-based molecular mechanics, and distributed data lakes, the platform transforms heterogeneous biological and clinical datasets into actionable mechanistic predictions. The technology accelerates rational drug design, clinical trial cohort optimization, and computerized diagnostic decision support, radically compressing empirical cycle times.
The technological platform unites containerized cloud computing architectures (Kubernetes, AWS/GCP), GPU-accelerated tensor computation, FHIR/HL7 healthcare interoperability standards, and cryptographically secure federated learning networks. Computational engines process petabyte-scale multi-omics registries, electronic health records (EHR), and 3D structural conformations with sub-angstrom spatial accuracy and milliseconds-per-query latency. Software lifecycle development strictly complies with IEC 62304 (Medical Device Software Lifecycle), ISO 27001 (Information Security), and FDA SaMD (Software as a Medical Device) guidelines, guaranteeing absolute data provenance, algorithmic reproducibility, and HIPAA/GDPR patient privacy.
The key directions of this technology are:
- AI Foundation Models & Molecular Representation Learning in Interactive Multi-Omics Data Exploration, Cohort Discovery, and Biological Insight Platform: Deploying billion-parameter multimodal transformers trained on evolutionary sequences, structural PDB coordinates, and clinical phenotypes to predict molecular interactions and toxicity liabilities.
- Physics-Based Molecular Dynamics & Quantum Mechanics: Coupling free energy perturbation (FEP+) and density functional theory (DFT) to calculate binding free energies of complex macromolecular complexes with chemical accuracy (<1 kcal/mol).
- Distributed Federated Learning & Privacy-Preserving Analytics: Training diagnostic neural networks across multi-hospital consortia using secure multi-party computation (SMPC) without centralizing sensitive patient health data.
- HL7 / FHIR Standardized Clinical Workflow Integration: Deploying SMART-on-FHIR RESTful APIs to deliver real-time AI decision support alerts directly into hospital electronic health record (EHR) workflows.
Sectoral value chain#
┌────────────────────────────────────────────────────────┐
│ Tier 1: Multimodal Data Ingestion & Harmonization │
│ (Genomic FASTQ, clinical EHR FHIR, DICOM imaging) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 2: Cloud Data Lakehouse & Feature Engineering │
│ (Distributed Spark pipelines, schema normalization) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 3: GPU-Accelerated AI Model Training & Inference │
│ (Tensor cores, transformer models, FEP+ simulation) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 4: Algorithmic Verification & Explainability Run │
│ (SHAP attribution, cross-validation, bias detection) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 5: Secure Microservice API & Clinical Dashboard │
│ (SMART-on-FHIR integration, encrypted cloud delivery) │
└────────────────────────────────────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Data Ingestion & Normalization | Automated parsing and de-identification of multi-omics files, unstructured clinical text, and medical imaging datasets. | In: Raw multi-omics data, hospital EHR logs, imaging DICOM. Out: Normalized, privacy-compliant feature data stores (OMOP/FHIR). |
| Distributed Data Lake Architecture | High-throughput data staging, indexing, and quality filtering on distributed cloud object storage systems. | In: Harmonized feature tables, cloud object store (S3/GCS). Out: Optimized Parquet/Zarr data lakehouse ready for training. |
| Model Execution & Neural Inference | GPU-accelerated training and inference execution across multi-layer transformer and structural neural architectures. | In: Curated training datasets, PyTorch/TensorFlow, GPU clusters. Out: Trained model weights and deterministic predictive outputs. |
| Algorithmic Validation & Bias Audit | Rigorous cross-validation across independent hold-out clinical cohorts and validation of explainability metrics. | In: Inference predictions, validation cohorts, ground truth. Out: Audited model performance dossier (AUROC > 0.92, F1 > 0.88). |
| Clinical Integration & Secure API Release | Deployment of containerized microservice APIs integrated into hospital EHR systems via SMART-on-FHIR standards. | In: Validated container image, API gateway, clinician portal. Out: Active clinical decision support service with audited logs. |
Cross-cutting technologies of the sector:
- Explainable AI (XAI) Attribution Mapping: Layer-wise relevance propagation and integrated gradients highlighting the exact molecular motifs or clinical features driving AI predictions.
- Post-Quantum Cryptographic Data Sharing: Lattice-based encryption protocols protecting genomic sequence registries and biobank access against future quantum decryption threats.
2 · What it replaces 3 · matched by industry
| D3E2 | Genomic selection in dairy cattle breeding instead of progeny testing Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs) | BREED |
| D3E– | Agricultural spraying drones instead of knapsack and manned aerial spraying Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying | EAC |
| D2E– | Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale … | MACRO |
3 · How to implement 4 steps
- 1Heterogeneous multi-omics data ingestion and normalizationStandardizing count matrices, VCF variants, and mass spectrometry peak intensities across platforms into unified schemas.
- 2Real-time visual cohort stratification and survival analyticsStratifying patient cohorts based on multi-omics gene expression signatures to compute Kaplan-Meier survival curves in real time.
- 3Biological pathway and gene regulatory network enrichmentProjecting altered molecular signatures onto KEGG, Reactome, and GO knowledge bases to uncover underlying mechanism of action.
- 4Secure federated multi-institution collaboration governanceEnabling cross-site pharmaceutical consortium data exploration with role-based masking and audit logging.
4 · Who delivers
Matched suppliers (matched automatically)
| MGI (BGI Group) | China | Producer | active |
| Rev Genomics | United States | Producer | active |
| Insilico Medicine | Cayman Islands | Producer | active |
| NatureMetrics | United Kingdom | Services / consulting | active |
| String Bio | India | Producer | active |
| Recursion Pharmaceuticals | United States | Research / RTO | active |
| Schrödinger | United States | Services / consulting | active |
| Caladan Bio | United States | Producer | active |
| Korea Nova | South Korea | Producer | active |
| Turion Labs | Singapore | Research / RTO | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Roche Diagnostics | 🇨🇭 Switzerland | Cobas Molecular & CLIA Analyzers | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
| Abbott Laboratories | 🇺🇸 United States | Alinity Automated Diagnostic Systems | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
| Thermo Fisher Scientific | 🇺🇸 United States | QuantStudio PCR & Genetic Analyzers | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
| Mindray Bio-Medical | 🇨🇳 China | High-Throughput Clinical Diagnostic Analyzers | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
| Siemens Healthineers | 🇩🇪 Germany | Atellica Integrated IVD & Imaging Platforms | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
| bioMérieux | 🇫🇷 France | FilmArray Syndromic Molecular Diagnostics | Standardized ISO 13485 / CLIA analytical validation and cGMP automated reagent packaging. | Commercial / Approved |
5 · Rules & route to market
import permit within 30 working days (conventional genetics); gene-edited animals: GMO registration
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
FDA Software as a Medical Device (SaMD) framework, Good Machine Learning Practice (GMLP)#
- FDA SaMD & AI/ML Action Plan: Regulatory qualification for Interactive Multi-Omics Data Exploration, Cohort Discovery, and Biological Insight Platform under FDA CDRH premarket software pathways with Predetermined Change Control Plans (PCCP).
- Good Machine Learning Practice (GMLP): Adherence to joint FDA-Health Canada-MHRA standards governing training data hygiene and model drift monitoring.
- HIPAA Compliance & SOC 2 Type II: Strict federal patient data privacy safeguards and annual third-party security audits across all cloud environments.
European Union
EU AI Act medical device classification, GDPR Article 22 compliance, CE marking#
- EU Artificial Intelligence Act (AI Act) High-Risk Classification: Comprehensive risk management, human oversight, and data governance for healthcare algorithms.
- GDPR Automated Decision-Making Safeguards: Strict adherence to Article 22 ensuring patients retain the right to human intervention and algorithm explainability.
- IEC 62304 Medical Device Software Lifecycle: Rigorous verification, validation, and automated defect tracking through formal software engineering lifecycles.
China
NMPA AI medical device classification, national big data computing hubs, hospital trials#
- NMPA AI Medical Device Class III Registration: Stringent clinical trial evaluation for 交互式多组学(Multi-Omics)全景大数据可视化探索、队列发现与生物学机制挖掘平台 software algorithms acting as medical diagnostic aids.
- National Eastern Data, Western Computing Strategy: Direct access to state-sponsored supercomputing infrastructure driving large-scale molecular AI training.
- Hospital Information Interoperability Standards: National Health Commission directives standardizing electronic medical record exchange and digital pathology data.
6 · Money: tenders & grants
| Grant | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · United States | Jul 5, 2029 955 days |
| Grant | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States | Aug 18, 2027 268 days |
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 326 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 428 days |
| Grant | Additional activities for the European Partnership of Agriculture of Data European Commission · EU | Nov 26, 2026 3 days |
7 · Tech stack & innovations
- Computational AI Engine in Interactive Multi-Omics Data Exploration, Cohort Discovery, and Biological Insight Platform:
- Billion-parameter transformer language models trained on hundreds of millions of biological sequences and chemical structures.
- Geometric deep learning architectures directly operating on 3D molecular point clouds and atomic coordinate graphs.
- High-Performance Cloud Infrastructure:
- Distributed Kubernetes clusters orchestrating multi-node GPU training jobs with InfiniBand low-latency interconnects.
- Automated MLOps pipelines managing dataset versioning, model registry checkpoints, and drift monitoring in production.
- Healthcare Interoperability Integration:
- Fast Healthcare Interoperability Resources (FHIR) JSON RESTful APIs supporting bidirectional EHR clinical workflows.
- OAuth 2.0 and OpenID Connect protocols enforcing fine-grained role-based access control across multi-institutional federations.
Sources 1 · 0 independent · 1 producer sites
Producers' own sites 1
- www.swissbiotech.org producer checked 2026-11-22